HSA — authorised 19 October 2007
- Marketing authorisation holder: GENZYME
- Status: likely_approved
HSA authorised Renvela on 19 October 2007
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 19 October 2007.
GENZYME holds the Singaporean marketing authorisation.